| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Laboratory of Immunopathology, Institute of Immuno-Hematology, Central Hospital, and
Department of Pathology, Hautepierre Hospital, University Hospitals of Strasbourg, Strasbourg, France; and
Basel Institute for Immunology, Basel, Switzerland
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Overall, TdT° mice appear healthy; they have been challenged with several pathogens and Ags and show no evidence of immunodeficiency. Likewise, no evidence of a propensity for autoimmune disease has been observed (1, 16, 17). This raises several questions. 1) How important is the diversity generated by TdT? 2) Why is this form of diversity developmentally regulated? Previous studies have reported that positive selection of T cells is more efficient in TdT° mice and that the T cell repertoire is more polyreactive and less peptide oriented than that in TdT+ animals (16, 17, 18, 19). Consequently, it has been speculated that the fetal/adult dichotomy may play a protective role against autoimmunity: the suppression of TdT during early T cell ontogeny, when self-reactive T cells are not efficiently deleted and the repertoire is self-directed, may help prevent the generation of T cells with high avidity anti-self receptors. Later in life, in addition to providing a more diverse T cell repertoire, TdT may lower the risk of pathogen-induced autoimmunity caused by cross-reactive T cells (19). We have recently demonstrated that the TdT° mutation alters the B cell preimmune repertoire in adult mice (20). In particular, TdT is not critical for the generation of B cells expressing low affinity natural autoantibodies, including anti-DNA Abs and rheumatoid factors. However, the frequencies of these clones in the preimmune repertoire are significantly lower than those in TdT+ mice, mainly due to a lower incidence of polyreactivity. Moreover, the lack of TdT seems to reduce the mean affinity of natural anti-DNA autoantibodies. Consequently, the suppression of TdT during early B cell ontogeny may prevent both high avidity anti-self recognition and extensive self multireactivity, which could increase the probability of activation of the individual B cells that express such natural autoantibodies.
Taken together, these data prompted us to study the impact of the suppression of TdT activity in a mouse strain prone to autoimmunity, particularly in a model in which anti-DNA autoantibodies seem to play an important pathogenic role. We therefore decided to introduce the TdT° null mutation into the lupus-prone (NZBxNZW)F1 (designated B/W) mouse strain for the additional following reasons. B/W mice spontaneously develop an autoimmune disease that resembles human systemic lupus erythematosus (SLE), including the occurrence of severe lethal glomerulonephritis (21, 22). IgG anti-dsDNA autoantibodies are the principal feature in both B/W mice and human SLE, and their presence correlates with nephritis (21, 22, 23). The relationship between pathological anti-DNA Abs and natural autoantibodies remains questionable. It is not yet clear whether pathological anti-DNA Abs originate from and are regulated by the pool of natural autoantibodies. Experiments using the B/W mouse strain suggest that during the initial stage of the disease, low affinity anti-ssDNA IgM autoantibodies arise as a by-product of polyclonal B cell activation, possibly involving an intrinsic B cell abnormality (24, 26, 27; reviewed in Ref. 25). During disease progression, pathogenic high affinity IgG anti-dsDNA autoantibodies may arise from this pool as a result of an Ag-driven expansion and maturation of a few B cell clones (24, 28, 29; reviewed in Refs. 25 and 30). The mechanisms underlying this breakdown of tolerance are still unclear; in particular, the respective roles of an abnormal B cell preimmune repertoire or T cell regulation have not been established. Given the potential impact of the suppression of TdT on the preimmune anti-DNA B cell pool, the study of TdT° B/W mice may contribute to resolving these issues.
Anti-dsDNA autoantibodies appear to play a major role in glomerulonephritis; however, the conclusions derived from many studies are that only a subset of these autoantibodies is pathogenic and that the structural/molecular properties of the nephritogenicity are still unclear. The presence of cationic residues, namely Arg, within the CDR regions, especially CDR3, of autoantibody heavy chains may be essential for their high affinity for dsDNA and their nephritogenic properties (29, 31; reviewed in Refs. 25 and 30). Arg residues are rare in CDR3 regions of Abs that do not bind DNA but can be generated by somatic mutations, N addition, or unusual V-(D)-J rearrangements (28, 29). The respective roles of these mechanisms remain to be elucidated, but the last two clearly depend on the action of TdT in the B cell population, whereas the first may be indirectly affected by the expression of this enzyme in the T cell pool.
In this study we show that introduction of the TdT° null mutation into B/W mice partially protects them from nephritis even though such mice produce equivalent amounts of anti-DNA and anti-histone autoantibodies as their TdT+ littermates. However, healthy TdT° B/W mice do not show evidence of renal inflammation, and although they have Ig glomerular deposits, the pattern is different from that observed in littermates with nephritis. These results may help to unravel the mechanisms of lupus nephritis and the molecular basis of nephritogenic autoantibodies.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
TdT° C57BL/6 mice carrying a mutation in the TdT gene and therefore deficient in this enzyme were provided by C. Benoist and D. Mathis (Institut de Genetique et de Biologie Moleculaire et Cellulaire, Strasbourg, France) (1). The mice were maintained in a conventional mouse facility. NZB and NZW mice were purchased from The Jackson Laboratory (Bar Harbor, ME). The TdT° allele was backcrossed separately onto the NZB and NZW inbred strains. Mice bearing the TdT° allele were identified by PCR analysis of tail DNA using a mixture of primers as described previously (19). The NZB and NZW mice of the fourth and sixth backcrosses (N4 and N6) heterozygous for the TdT° allele were intercrossed, and the N4F1 and N6F1 progeny was analyzed. The TdT°/+ and TdT+/+ littermates designated as a whole TdT+ were used as controls. Only female animals were used in the present study.
Microsatellite mapping using simple sequence length polymorphisms
Since both NZB and NZW MHC (H2) loci have been shown to be linked with lupus traits (reviewed in Refs. 32 and 33), we have selected the NZB and NZW TdT°/+ mice with H-2d and H-2z, respectively, in the second backcross generation for the subsequent crosses. This was performed using Southern blot analysis with an Aßk cDNA probe.
Oligonucleotides flanking simple sequence repeats were
synthesized at the Institut de Genetique et de Biologie Moleculaire et
Cellulaire and end-terminally labeled with [
-32P]ATP.
The relative positions of the markers and the sequences of the primers
were obtained from The Mouse Genome Database of The Jackson Laboratory
via internet at (http://www.informatics.jax.org/mgd html). When the
markers that have been described to map the susceptibility loci in
NZB/W mice were not polymorphic between the C57BL/6–129 and the
NZB/NZW alleles, other neighboring markers were used. Amplification of
the simple sequence repeats was achieved by PCR using tail DNA in a
PTC-100 thermal cycler (MJ Research, Watertown, MA). The program for
PCR reactions (total volume, 20 µl) was generally 30 cycles of
30 s at 94°C, 30 s at 54°C, and 1 min at 72°C. PCR
products were run on 8% polyacrylamide gels at 12 V/cm for 2–3 h. The
autoradiographies obtained were scored appropriately.
Segregants from the fourth backcross were genotyped with the following linkage markers (loci contributing to SLE susceptibility are indicated in bold): D1 Mit33 (34), D1 Mit15(Sle1) (34), D1 Mit36(Lbw7) (35), D1 Mit221 (36), D4Nds2(Lbw2) (35), D4 Mit12 (36), D4 Mit48 (37), D5 Mit10(Lbw3) (35), D6 Mit25(LbW4) (35), D7 Mit70 (34), D18 Mit8(Lbw6) (35), and D18 Mit 142. At the N4 backcross generation, heterozygotes for NZB/NZW alleles at most of the linkage markers were used for the intercrosses and for further backcrosses. BW N4F1 mice were genotyped using the same markers.
Evaluation of renal disease
Mice were evaluated weekly for proteinuria using Usistix (Bayer
Diagnostics, Puteaux, France). Urine samples were graded 0 to 4+,
corresponding to the following approximate protein concentrations:
0 = negative or trace; 1+ = 30 mg/dl; 2+ = 100 mg/dl; 3+ = 300
mg/dl; 4+ = 
2000 mg/dl. Mice with negative determinations of
proteinuria and no evidence of disease up to 12 mo of age were
identified as not expressing lupus-like disease and were allocated a
negative disease phenotype; they were arbitrarily designated long-term
survivors. Mice with significant proteinuria (3+) on two or more
consecutive examinations before 12 mo of age were designated positive
for renal disease.
Histological analysis
The severely ill and wasted mice with evidence of renal disease
were killed for kidney collection when they appeared moribund. Mice
that were killed were counted as deaths at the time they were killed in
Fig. 1
B. The mice with no evidence of
renal disease were killed at the end of the study at 12 mo.
|
IgM, IgG, and IgG subclass deposits were assessed by immunofluorescence on kidney cryocut section using fluorescein-conjugated rat anti-mouse IgG, IgM, IgG1, IgG2a, IgG2b, or IgG3 (PharMingen, San Diego, CA). All Abs were used at a 1/5 dilution and were incubated for 20 min at room temperature. After washing with PBS, pH 7.2, for 6 min, the sections were counterstained with Evans blue. The sections were scored on a 0 to 3+ scale.
ELISA and serological assays
The mice were bled by retro-orbital puncture under anesthesia at monthly intervals from the age of 4 mo. The sera were stored at -20°C until analysis for Ab levels.
Total levels of IgM, IgG, IgG1, IgG2a, IgG2b, and IgG3 were determined
by ELISA. For IgG subclasses, microtiter plates (Nunc, Roskilde,
Denmark) were coated with goat anti-mouse IgG/M(H+L) Abs (Jackson
ImmunoResearch Laboratories, West Grove, PA) at 5 µg/ml in PBS
overnight at 4°C. After washing and saturation for 30 min at 37°C
with PBS and 1% BSA, serum samples were titrated in PBS containing
0.1% Tween-20 and 0.5% gelatin and incubated at room temperature.
After washing with PBS and 0.1% Tween 20, plates were incubated
with alkaline phosphatase-labeled goat Abs specific for mouse IgG
subclasses (Southern Biotechnology Associates, Birmingham, AL) at 0.2
µg/ml for 60 min at room temperature. After a final wash the plates
were developed with paranitrophenyl phosphate substrate (Sigma, St.
Louis, MO), and the OD405 nm was determined in a
Titertek Multiskan reader (Labsystems Multiskan RC, Helsinki,
Finland). The results were expressed in absorbance units. IgG
and IgM serum levels were assessed as previously described (20).
Briefly, wells were coated with goat Abs to mouse µ- or -chain
(Jackson ImmunoResearch Laboratories) at 1 µg/ml. Samples were
incubated overnight at 4°C. Standard curves were obtained with
murine IgG or IgM (Jackson ImmunoResearch Laboratories). The plates
were then incubated with peroxidase-conjugated goat anti-mouse
(µ- or )-chain Ab. Following incubation with substrate
O-phenylenediamine (Sigma), the plates were read at
OD492 nm.
Titers of IgG and IgM anti-dsDNA and anti-ssDNA autoantibodies were determined by ELISA as described previously (20). For dsDNA reactivity, wells were treated with a 1% solution of aqueous protamine sulfate, and calf thymus DNA was adsorbed at 10 µg/ml. After washing, ssDNA was removed by digestion with S1 nuclease (100 U/ml). For ssDNA reactivity, the plates were coated with 5 µg/ml of single-stranded calf thymus DNA (Sigma). For both assays, the bound autoantibodies were detected with the specific peroxidase-conjugated goat anti-mouse Ig (Jackson ImmunoResearch Laboratories). Titers of IgG1, IgG2a, IgG2b, and IgG3 anti-dsDNA Ab were determined by ELISA using subclass-specific Abs (Southern Biotechnology Associates). In all assays, the titers are the highest dilutions still giving a positive signal (log2 titers) in the ELISA in which twofold serum dilutions were tested starting from a 1/100 dilution.
The Crithidia luciliae assay was used to detect high affinity IgG anti-dsDNA in the sera. C. luciliae slides (Immunoconcepts, Sacramento, CA) were incubated with 1/10 to 1/320 serum dilutions and developed with a fluorescein-labeled anti-murine IgG Ab (Jackson ImmunoResearch Laboratories).
Titers of IgG and IgM anti-histone autoantibodies were assessed by ELISA. Microtiter plates were coated overnight at 37°C with 10 µg/ml of histone H1, H2A, H2B, H3, or H4 in PBS buffer. The histones were purchased from Boehringer Mannheim (Mannheim, Germany). After washing and saturation with PBS/BSA, serum samples were diluted in 0.5% PBS containing 0.1% Tween 20 and 0.5% gelatin and incubated overnight at 4°C. After washing, plates were incubated with the relevant peroxidase-conjugated goat anti-mouse Ig (Jackson ImmunoResearch Laboratories). The titers are the highest dilutions still giving a positive signal (log2 titers) in the ELISA in which twofold serum dilutions were tested starting from a 1/100 dilution.
All ELISA assays were performed in triplicate. In each test, sera from MRL lpr/lpr and BALB/c mice were included as positive and negative controls, respectively.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We studied 20 female mice B/W F1 from the N4 backcross generation. Thirteen were homozygous for the TdT° mutation. All mice were genotyped by PCR for the 12 microsatellite markers described in Materials and Methods that were previously shown to be closely linked to nephritis, death, and anti-chromatin autoantibody production in the B/W F1 model (33, 34, 35, 36, 37). The results indicate that all the mice were B/W heterozygous at the Sle1, Lbw5, Lbw6, and Lbw7 loci (not shown). The presence of 129 or B6 alleles at the other loci was occasionally observed in some TdT+ and TdT° mice, with no significant differences between the two groups.
TdT deficiency reduces the development of significant proteinuria and prolongs survival in B/W F1 mice
To follow the progression of renal disease, B/W F1 N4
female mice were evaluated weekly from 4–12 mo of age for the presence
of proteinuria (Fig. 1
A). The mice with a dipstick reading
of 3+ (proteinuria 300 mg/dl) or higher on at least two consecutive
examinations were considered positive for renal disease. Fewer TdT°
mice than TdT+ littermates developed significant
proteinuria by 6 mo of age and throughout the remainder of the study.
By the end of the study, only 31% of the TdT° mice (4 of 13) vs
100% of the TdT+ mice (7 of 7) had developed evidence of
significant proteinuria (p < 0.02, by
Mann-Whitney U test).
Consistent with the partial protection against renal disease, TdT
deficiency significantly enhanced survival in B/W F1 mice
(Fig. 1B). This effect was already apparent at 7 mo of age,
at which stage 90% of the TdT° mice were alive vs 40% of the
control group. By the end of study all the TdT+ mice had
presented evidence of severe nephritis and were dead, whereas 9 of 13
TdT° mice were alive and had no proteinuria
(p < 0.02, by Mann-Whitney U test).
For clarity, we refer to these nine mice as long-term survivors.
We also studied a group of B/W F1 female mice from the
sixth backcross generation (15 TdT+ and 7 TdT°). At 6 mo
of age, 9 of 15 TdT+ vs 0 of 7 TdT° mice had developed
nephritis (p < 0.02, by Mann-Whitney
U test). During the further follow-up, all the TdT° mice
remained healthy, without proteinuria, and four (aged 6–9 mo) were
sacrificed for the generation of hybridomas. At 1 yr of age, the three
remaining TdT° animals were still healthy, whereas 14 of 15
TdT+ mice had developed severe nephritis before reaching
this age. Fig. 1C depicts the cumulative percent survival
curve of all the TdT+ (n = 22) and TdT°
(n = 20) B/W N4 and N6 mice (Kaplan-Meier analysis). In
this analysis the four healthy TdT° N6 mice that were sacrificed were
considered censored cases. As showed in Fig. 1, by the end of study,
only 4 of 20 TdT° mice vs 21 of 22 TdT+ mice had
presented evidence of severe nephritis and were dead
(p < 0.0001, by log-rank test).
Therefore, the data from B/W N6 mice confirmed that TdT deficiency induced significant protection against nephritis and enhanced survival in B/W mice. Since N4 and N6 mice had similar clinical phenotypes, the results to be presented below concern only B/W N4 female mice.
TdT deficiency significantly reduces the development of proliferative glomerulonephritis in B/W F1 mice
Kidney specimens from all mice were examined by light and
immunofluorescent microscopy for the presence of glomerulonephritis and
Ig deposits. The animals showing no evidence of renal disease were
sacrificed at the end of the study at 12 mo. The results are presented
in Table I and Fig. 2. All the TdT+ mice and all
the TdT° animals with proteinuria developed lesions typical of severe
proliferative glomerulonephritis, including reduced numbers of
discernible glomeruli with fibrinoid necrosis and sclerosis, increased
mesangial and glomerular cellularity with loss of normal architecture,
crescent formations, and tubular alterations such as dilatation and
cast formation (Fig. 2, B and C). In contrast,
histologic examination of kidneys from clinically healthy TdT° mice
killed at 12 mo revealed no significant glomerular or tubular disease
(Fig. 2A). Indeed, the sections were difficult to
distinguish from the BALB/c controls.
|
|
and Fig. 2, D–F). However, the patterns were clearly different.
Moderate to intense mesangial and capillary wall granular deposits were
observed in TdT+ and TdT° mice with nephritis with no
significant differences between the two groups. In contrast, capillary
wall staining could not be detected in long-term survivor TdT°
animals. We also examined the IgG subclass deposits in two mice
randomly selected in each of these three groups. Similar mesangial
deposits of all IgG subclasses with a predominance of IgG2a and IgG3
were detected in all mice. However, IgG capillary wall staining was
only present in TdT+ and TdT° with nephritis; the
deposited IgG consisted of IgG2a and IgG3. Thus, the absence of
proteinuria in TdT° animals correlated well with the absence of renal
pathology and with the absence of capillary wall Ig deposition. In
addition, the histologic examination of the kidneys from 14
TdT+ N6 animals with clinical evidence of renal disease
revealed lesions typical of severe proliferative glomerulonephritis as
described above. In contrast, analysis of kidneys from the sacrificed
TdT° littermates revealed no glomerular disease (not shown). TdT deficiency does not prevent the production of hypergammaglobulinemia and autoantibodies
Because of the potential role of certain autoantibodies in the pathogenesis of renal disease in B/W F1 mice, we examined whether the beneficial effect of TdT deficiency could be related to a disability to generate humoral autoimmunity. For this, the mice were bled monthly to measure serum levels of Ig isotypes and autoantibodies against ssDNA, dsDNA, and individual histones. Serum Ig isotypes were measured at 4 and 9 mo of age (or, in the case of mice that died before reaching this age, i.e., four TdT+ and one TdT°, in the last sample). At 4 mo of age all mice produced significantly increased amounts of IgM and all IgG subclasses compared with normal BALB/c mice housed in the same environment. The high IgG serum levels were mainly attributable to an increased production of IgG2a and IgG3. It is worth noting that there were no substantial differences among the three groups of mice. At 9 mo of age, similar observations were made for IgM, IgG2a, and IgG3; however, only TdT° long-term survivors still presented increased levels of IgG2b (data not shown).
Titers of IgG and IgM autoantibodies against dsDNA, H2A, and H2B were
evaluated monthly. Results of these analyses at 5, 6, and 8 mo of age
are represented in Figs. 3 and
4. Surprisingly, each type of
autoantibody developed at levels comparable among the three groups of
mice, albeit variable within each group. Similar results were obtained
for IgG and IgM against ssDNA, H1, H3, and H4 (not shown). Considering
that the C. luciliae assay may provide a more stable and
specific substrate than ELISA for the determination of anti-dsDNA
activity (40), we also examined serum binding to Crithidia
kinetoplast. Again, there were no significant differences in
anti-dsDNA titers among the three groups of mice (data not shown).
In B/W F1 mice anti-dsDNA autoantibodies are
predominantly of the IgG2a isotype (reviewed in Refs. 21 and 41); to
determine whether TdT deficiency could alter the subclass profiles of
IgG anti-dsDNA, we examined the serum from mice at 8 mo of age (IgG
anti-dsDNA titers increased over time, generally reaching their
maximum level at this age; for mice that were already dead, we used the
last sample before death). As shown in Fig. 5, the levels of IgG1, IgG2a, and IgG3
anti-dsDNA were comparable among the three groups of animals; in
fact, the only significant difference consisted of higher IgG2b titers
in TdT° long-term survivors compared with those in TdT+
littermates (p < 0.01, by Mann-Whitney
U test).
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Since most of the data presented in this study concern the N4 backcross generation, it may be argued that the disease resistance in the B/W F1 TdT° stock could be ascribed to the presence of 129- or B6-derived resistance alleles. We think this very unlikely for the following reasons. 1) All the studied mice were heterozygotes H2d/z; B/W MHC heterozygosity represents the most important contribution to disease from each strain (H2d/z vs H2d/d for NZB and H2z/z for NZW). 2) Our genotypic analysis did not reveal any bias for the presence of 129 or B6 allele in the long-term survivor group. 3) The TdT+ segregants developed the disease at the expected rate. 4) Preliminary data from the N6 backcross generation confirm our results; at about 6 mo of age, 9 of 15 TdT+ vs 0 of 7 TdT° mice had developed nephritis (p < 0.02). 5) While numerous SLE susceptibility loci have been described, none linked with nephritis has been mapped to chromosome 19 where TdT is located.
The mechanism(s) by which TdT deficiency reduces the development of autoimmune nephritis remains to be elucidated. Although the exact mechanisms of nephritis in B/W mice are still under debate, the following statements are best supported by the existing data (reviewed in Refs. 41 and 42). 1) Nephritogenic autoantibodies represent the proximal cause of the glomerulonephritis. 2) They probably comprise a family of autoantibodies that binds to epitopes on chromatin (including but not limited to dsDNA). 3) Imune complex (formed either in the circulation or in situ) deposits in the kidney induce disease by activating the complement. 4) These deposits may relate to the propensity of the immune complexes to bind via the autoantigen to components of the glomerular basal membrane, such as type IV collagen, heparan-sulfated glycosaminoglycans or anionic phospholipids. In our study nephritis is closely correlated with the subendothelial deposition of IgG and mainly of IgG2a and IgG3 in both TdT+ and TdT° animals. In contrast, mesangial immune deposits per se do not seem to induce renal lesions; this is reminiscent of the fact that in human SLE, mesangial Ig deposits are a common finding and are not indicative of nephritis. Our results are also in accord with adoptive or passive transfer experiments with either anti-DNA hybridomas or anti-DNA mAbs, which usually resulted in mesangial Ig deposits with a subsequent mild mesangial hypercellularity (43, 44, 45). Very few anti-DNA mAb (mAb H147 (45), 6-19 (46), and 11F8 (47)) have been shown to induce severe proliferative glomerulonephritis upon adoptive transfer; in these cases, immunofluorescence revealed intense mesangial and subendothelial immune deposits. We also show in this study that TdT does not alter the subclass profiles of the immune deposits. Taken together, our findings indicate that the absence of nephritis in a large proportion of TdT° mice is not explained by a different subclass composition of the immune deposits and consequently by their failure to activate the complement; rather, it may be related to the variation in their location, which, in turn, is probably influenced by the antigenic specificities of the deposited IgG.
Therefore, the most immediate conclusion is that TdT deficiency hampers
the production of nephritogenic Abs. Such Abs induce nephritis and/or
immune deposits presumably because they are somatically mutated and
class switched by 
ß T cell-dependent mechanisms. The molecular
basis of nephritogenicity is, however, still controversial; this is due
in part to technical problems (for instance, several monoclonal
anti-dsDNA capable of inducing nephritis when injected into
nonautoimmune mice may actually be antinucleosome Abs). The lack of
consensus regarding the definition of nephritis, as mentioned above,
further muddies the water. Keeping in mind these restrictions, the
autoantibodies most closely associated with nephritis are anti-DNA
Abs. To be precise, only a subset of anti-DNA Abs is probably
nephritogenic; they are predominantly of the IgG isotype with high
affinity binding preference for dsDNA; their V regions and in
particular the H-CDR3 are frequently enriched with charged residues,
namely arginines and aspartic acids (reviewed in Refs. 25 and 30). One
notable feature is that many of these residues have been generated by N
addition and/or specific V-D rearrangements, both of which are
TdT-dependent mechanisms. In B/W mice, low affinity anti-DNA IgM
autoantibodies arise as a by-product of polyclonal B cell activation,
possibly involving an intrinsic B cell abnormality (24, 26, 27;
reviewed in Ref. 25). In the course of the disease, pathogenic high
affinity anti-dsDNA seem to arise from this pool as a result of an
Ag-driven expansion and maturation of a few B cell clones (24, 28, 29).
Since TdT deficiency significantly reduces both the number of
anti-DNA B cells and the mean affinity of anti-DNA IgM in adult
normal mice (20), the probability of such B cells being efficiently
activated to undergo an Ag-driven maturation may be significantly
reduced in TdT° mice, resulting in the partial protection against
nephritis observed in our study.
However, in this view it is surprising that long-term survivor B/W F1 TdT° mice develop similar serum levels of anti-dsDNA, particularly of the IgG2a and IgG3 isotypes, as their TdT° and TdT+ littermates with nephritis. Several hypotheses can be considered.
First, nephritogenicity and high affinity for dsDNA without proteins may be separate properties as suggested by recent publications (48, 49, 50, 51). In support of this statement, Rubin has provided evidence that Abs to other epitopes on chromatin (especially H2A/H2B) are more highly associated with nephritis than are Abs to dsDNA in humans with lupus (52). However, in our study anti-H2A/H2B IgG serum levels were not significantly different in the three groups of mice. Other epitopes may be important, as mentioned below.
Second, the development of renal disease in B/W mice is certainly a multistep process. SCID mice populated with pre-B cells from B/W mice produce hypergammaglobulinemia of IgM, IgG2a, and IgG3 and high titers of antinuclear autoantibodies, suggesting that these features are due to intrinsic B cell abnormalities (26, 27). It is therefore not surprising that TdT° mice share these properties. TdT deficiency may protect against nephritis by a direct effect on the fine specificities and/or affinities of these autoantibodies or by altering the T cell repertoire. It has been suggested that polyreactivity may be a distinguishing feature of nephritogenic autoantibodies (53, 54, 55, 56). The experimental support for this hypothesis was derived from kidney eluate Ig characterizations and from mAb studies that suggested that anti-DNA Abs could bind directly to components of the glomerular basal membrane (44, 53, 54). In this respect it is noteworthy that TdT deficiency seems to particularly hamper the generation of polyreactive anti-DNA Abs (20).
Third, the reduced incidence of autoimmune nephritis in TdT° mice may
be due to a lack of expression of TdT in T cells. In B/W F1
mice, the production of somatically mutated anti-DNA and
anti-nucleosome IgG and the development of nephritis are clearly
dependent on T cell help (57, 58, 59). It has been proposed these Th cells
may be specific either for DNA binding proteins such as histones or for
peptides derived from the variable regions of the anti-DNA Abs
themselves. Particularly interesting is that their TCRs seem enriched
with anionic residues generated by N addition (60, 61). Presumably,
these negatively charged amino acids are critical for the binding of
cationic peptides derived from DNA binding proteins or from
anti-DNA Abs V regions. Consequently, we may speculate that TdT
deficiency could significantly impair the generation of such TCR.
Alternatively, in view of our serologic data, T cells may play a role
in the development of nephritis (i.e., in an autoantibody-independent
manner); this possibility is supported by data from Craft’s group
showing that MRL mice deficient in ß T cells develop immune
deposits in kidney without overt glomerulonephritis (62). The identity
of the disease-relevant cells remains a mystery.
The data reported here indicate that although murine lupus is a complex genetic trait with contributions from the MHC and multiple other genes, the suppression of TdT and the resulting restriction of the B and TCR diversity are sufficient to significantly protect against autoimmune nephritis. The most plausible reason is that the absence of N nucleotides considerably hampers the generation of nephritogenic autoantibodies and/or pathogenic T cells. The respective role of the T and B cells will be evaluated by adoptive transfer experiments. Interestingly, these results are almost certainly not restricted to the B/W model, since the TdT° mutation also appears to protect against insulitis when backcrossed onto the nonobese diabetic background (S. Gilfillan, unpublished observations). They suggest that TdT suppression may offer a new therapeutic strategy to prevent or control autoimmune diseases. Finally, these findings support the hypothesis that the controlled expression of TdT during the fetal and neonatal periods may be in part an insurance against autoimmunity. Introducing extensive self-multireactivity and recognizing self with too much avidity at a period when the Ag receptor repertoires are mainly self-directed and when autoreactive T cells are less efficiently deleted could be deleterious.
|
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Thierry Martin, Laboratoire d’Immunopathologie, Institut d’Immuno-Hematologie, Hôpital Civil, 1 place de l’Hôpital, 67000 Strasbourg, France. E-mail address:
3 Abbreviations used in this paper: TdT, terminal deoxynucleotidyl transferase; TdT°, terminal deoxynucleotidyl transferase knockout mice; SLE, systemic lupus erythematosus; CDR3, third complementary-determining region.
Received for publication June 5, 1998. Accepted for publication August 11, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
genes: implications for T cell lineages and for a novel intermediate of V-(D)-J joining. Cell 59:859.[Medline]
/ß T cells in neonatal mice. EMBO J. 10:3647.[Medline]
-chain is diverse and distinct from that of fetal thymocytes. Nature 331:627.[Medline]
ß T cells. J. Immunol. 156:4041.[Abstract]
This article has been cited by other articles:
|
|
 |
|
  J. B. Carey, C. S. Moffatt-Blue, L. C. Watson, A. L. Gavin, and A. J. Feeney Repertoire-based selection into the marginal zone compartment during B cell development J. Exp. Med., September 1, 2008; 205(9): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. M. Haeryfar, H. D. Hickman, K. R. Irvine, D. C. Tscharke, J. R. Bennink, and J. W. Yewdell Terminal Deoxynucleotidyl Transferase Establishes and Broadens Antiviral CD8+ T Cell Immunodominance Hierarchies J. Immunol., July 1, 2008; 181(1): 649 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fazilleau, C. Delarasse, I. Motta, S. Fillatreau, M.-L. Gougeon, P. Kourilsky, D. Pham-Dinh, and J. M. Kanellopoulos T Cell Repertoire Diversity Is Required for Relapses in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis J. Immunol., April 15, 2007; 178(8): 4865 - 4875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bodano, A. Gonzalez, I. Ferreiros-Vidal, E. Balada, J. Ordi, P. Carreira, J. J. Gomez-Reino, and C. Conde Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility Rheumatology, July 1, 2006; 45(7): 819 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. de Magalhaes, J. A. S. Cabral, and D. Magalhaes The Influence of Genes on the Aging Process of Mice: A Statistical Assessment of the Genetics of Aging Genetics, January 1, 2005; 169(1): 265 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lawman, C. Mauri, E. C. Jury, H. T. Cook, and M. R. Ehrenstein Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice J. Immunol., December 15, 2004; 173(12): 7641 - 7646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. F. Robey, M. Peterson, M. S. Horwitz, D. H. Kono, T. Stratmann, A. N. Theofilopoulos, N. Sarvetnick, L. Teyton, and A. J. Feeney Terminal Deoxynucleotidyltransferase Deficiency Decreases Autoimmune Disease in Diabetes-Prone Nonobese Diabetic Mice and Lupus-Prone MRL-Faslpr Mice J. Immunol., April 1, 2004; 172(7): 4624 - 4629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Balabanian, J. Couderc, L. Bouchet-Delbos, A. Amara, D. Berrebi, A. Foussat, F. Baleux, A. Portier, I. Durand-Gasselin, R. L. Coffman, et al. Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus J. Immunol., March 15, 2003; 170(6): 3392 - 3400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Schuster, T Martin, L Marcellin, J-C Garaud, J-L Pasquali, and A S Korganow Expansion of marginal zone B cells is not sufficient for the development of renal disease in NZBxNZW F1 mice Lupus, May 1, 2002; 11(5): 277 - 286. [Abstract] [PDF]
|
|
|
